» Articles » PMID: 18378638

Analysis of the Actinobacillus Pleuropneumoniae ArcA Regulon Identifies Fumarate Reductase As a Determinant of Virulence

Overview
Journal Infect Immun
Date 2008 Apr 2
PMID 18378638
Citations 21
Authors
Affiliations
Soon will be listed here.
Abstract

The ability of the bacterial pathogen Actinobacillus pleuropneumoniae to grow anaerobically allows the bacterium to persist in the lung. The ArcAB two-component system is crucial for metabolic adaptation in response to anaerobic conditions, and we recently showed that an A. pleuropneumoniae arcA mutant had reduced virulence compared to the wild type (F. F. Buettner, A. Maas, and G.-F. Gerlach, Vet. Microbiol. 127:106-115, 2008). In order to understand the attenuated phenotype, we investigated the ArcA regulon of A. pleuropneumoniae by using a combination of transcriptome (microarray) and proteome (two-dimensional difference gel electrophoresis and subsequent mass spectrometry) analyses. We show that ArcA negatively regulates the expression of many genes, including those encoding enzymes which consume intermediates during fumarate synthesis. Simultaneously, the expression of glycerol-3-phosphate dehydrogenase, a component of the respiratory chain serving as a direct reduction equivalent for fumarate reductase, was upregulated. This result, together with the in silico analysis finding that A. pleuropneumoniae has no oxidative branch of the citric acid cycle, led to the hypothesis that fumarate reductase might be crucial for virulence by providing (i) energy via fumarate respiration and (ii) succinate and other essential metabolic intermediates via the reductive branch of the citric acid cycle. To test this hypothesis, an isogenic A. pleuropneumoniae fumarate reductase deletion mutant was constructed and studied by using a pig aerosol infection model. The mutant was shown to be significantly attenuated, thereby strongly supporting a crucial role for fumarate reductase in the pathogenesis of A. pleuropneumoniae infection.

Citing Articles

Comparative Efficacy in Challenge Dose Models of a Toxin Expressing Whole-Cell Vaccine against Eight Serovars of in Pigs.

Mortensen P, Toft N, Kiss I, Palya V, Smits H, Tenk M Animals (Basel). 2022; 12(23).

PMID: 36496765 PMC: 9740876. DOI: 10.3390/ani12233244.


The Metabolic Adaptation in Response to Nitrate Is Critical for Actinobacillus pleuropneumoniae Growth and Pathogenicity under the Regulation of NarQ/P.

Zhang Q, Tang H, Yan C, Han W, Peng L, Xu J Infect Immun. 2022; 90(9):e0023922.

PMID: 35938858 PMC: 9476948. DOI: 10.1128/iai.00239-22.


Rationally designed vectors for functional genomic analysis of and other species by transposon-directed insertion-site sequencing (TraDIS).

Bosse J, Li Y, Leanse L, Zhou L, Chaudhuri R, Peters S Anim Dis. 2021; 1(1):29.

PMID: 34870287 PMC: 8616859. DOI: 10.1186/s44149-021-00026-4.


The effect of ArcA on the growth, motility, biofilm formation, and virulence of Plesiomonas shigelloides.

Yan J, Li Y, Guo X, Wang X, Liu F, Li A BMC Microbiol. 2021; 21(1):266.

PMID: 34607564 PMC: 8489083. DOI: 10.1186/s12866-021-02322-y.


Link between Heterotrophic Carbon Fixation and Virulence in the Porcine Lung Pathogen Actinobacillus pleuropneumoniae.

Konze S, Abraham W, Goethe E, Surges E, Kuypers M, Hoeltig D Infect Immun. 2019; 87(9).

PMID: 31285248 PMC: 6704602. DOI: 10.1128/IAI.00768-18.


References
1.
Deslandes V, Nash J, Harel J, Coulton J, Jacques M . Transcriptional profiling of Actinobacillus pleuropneumoniae under iron-restricted conditions. BMC Genomics. 2007; 8:72. PMC: 1832192. DOI: 10.1186/1471-2164-8-72. View

2.
Blackstock W, Di Modugno V, Holland I, Kok M . Two-component systems in Haemophilus influenzae: a regulatory role for ArcA in serum resistance. Infect Immun. 2002; 71(1):163-72. PMC: 143216. DOI: 10.1128/IAI.71.1.163-172.2003. View

3.
Jacobsen I, Hennig-Pauka I, Baltes N, Trost M, Gerlach G . Enzymes involved in anaerobic respiration appear to play a role in Actinobacillus pleuropneumoniae virulence. Infect Immun. 2004; 73(1):226-34. PMC: 538954. DOI: 10.1128/IAI.73.1.226-234.2005. View

4.
Miki K, Wilson T . Proton translocation associated with anaerobic transhydrogenation from glycerol 3-phosphate to fumarate in Escherichia coli. Biochem Biophys Res Commun. 1978; 83(4):1570-5. DOI: 10.1016/0006-291x(78)91400-6. View

5.
Ge Z . Potential of fumarate reductase as a novel therapeutic target in Helicobacter pylori infection. Expert Opin Ther Targets. 2002; 6(2):135-46. DOI: 10.1517/14728222.6.2.135. View